Patent Assignment
Reel/Frame 052607/0818
Change of Name
Recorded: 2020-05-07
Pages: 5
Assignor
THRESHOLD PHARMACEUTICALS, INC.
Executed: 2017-08-01
Assignee
MOLECULAR TEMPLATES, INC.
9301 AMBERGLEN BLVD.,, SUITE 100, AUSTIN, TEXAS, 78729
Covered Properties
(6)
Method for Determining Susceptibility of Tumor to Treatment with Anti-Neoplastic Agent
Anti-Cancer Therapies
Treatment of Cancer with Glufosfamide in Patients Not Receiving Insulin Therapy
Camptothecin Derivatives
Anti-Cancer Therapies
Phosphoramidate Alkylator Prodrugs
Related Assignments
(9)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
May 28, 2008
From: TIDMARSH, GEORGE
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 021011/0265 →
Assignment of Assignor's Interest
Jan 8, 2010
From: HANDISIDES, DAMIAN; KROLL, STEWART; DUAN, JIAN-XIN; SELICK, HAROLD E.
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 023753/0654 →
Assignment of Assignor's Interest
Mar 2, 2012
From: CAI, XIAOHONG; DUAN, JIAN-XIN; MATTEUCCI, MARK; CAO, YEYU
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 027800/0432 →
Assignment of Assignor's Interest
Nov 4, 2015
From: MATTEUCCI, MARK; DUAN, JIAN-XIN; JIAO, HAILONG
To: THRESHOLD PHARMACEUTICALS, INC.
Reel/Frame 036958/0762 →
Security Agreement
Feb 28, 2018
From: MOLECULAR TEMPLATES OPCO, INC.; MOLECULAR TEMPLATES, INC.
To: PERCEPTIVE CREDIT HOLDINGS II, LP
Reel/Frame 045466/0472 →
Release of Security Interest
May 22, 2020
From: PERCEPTIVE CREDIT HOLDINGS II, LP
To: MOLECULAR TEMPLATES OPCO, INC.
Reel/Frame 052733/0890 →
Assignment of Assignor's Interest
Jun 2, 2021
From: MOLECULAR TEMPLATES, INC.
To: IMMUNOGENESIS, INC.
Reel/Frame 056414/0241 →
Assignment of Assignor's Interest
Oct 26, 2022
From: MOLECULAR TEMPLATES, INC.
To: IMMUNOGENESIS, INC.
Reel/Frame 061545/0067 →
Security Interest
Jun 16, 2023
From: MOLECULAR TEMPLATES, INC.
To: ANKURA TRUST COMPANY, LLC, AS COLLATERAL TRUSTEE
Reel/Frame 063979/0709 →